Common Causes of Postmenopausal Bleeding in Korean Women: 10-Year Outcomes from a Single Medical Center.
10.3346/jkms.2017.32.5.830
- Author:
Min Kyoung KIM
1
;
Yeon Soo JUNG
;
Seung Joo CHON
;
Bo Hyon YUN
;
SiHyun CHO
;
Young Sik CHOI
;
Byung Seok LEE
;
Seok Kyo SEO
Author Information
1. Department of Obstetrics and Gynecology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. tudeolseo@yuhs.ac
- Publication Type:Original Article
- Keywords:
Postmenopausal Bleeding;
Common Cause of Postmenopausal Bleeding;
Korean Postmenopausal Women;
Hormone Replacement Therapy
- MeSH:
Atrophy;
Endometrial Neoplasms;
Female;
Hemorrhage*;
Hormone Replacement Therapy;
Humans;
Medical Records;
Polyps;
Prevalence;
Retrospective Studies;
Uterine Cervical Neoplasms;
Western World
- From:Journal of Korean Medical Science
2017;32(5):830-834
- CountryRepublic of Korea
- Language:English
-
Abstract:
The common causes of postmenopausal bleeding (PMB), according to the data from the western world, are atrophy, hormone replacement therapy (HRT), endometrial cancer, etc. We conducted a retrospective study to assess whether the causes of PMB in Korean postmenopausal women are similar to those already known. This retrospective study used 10-year medical records (March 2005 to December 2014) of 792 PMB women in the Yonsei University Health System. The data were divided into 2 categories by 5-year intervals to compare the differences between the 2 periods. The most common cause of PMB in Korean women was atrophy (51.1%). Polyps and HRT were the second, followed by anticoagulant medications, cervical cancer, and endometrial cancer. The proportion of patients with cervical cancer significantly decreased during the second half of the decade (8.7% vs. 5.2%; P = 0.048). Although no significant change was noted for HRT, its rank was higher during the latter 5-year period. Only the most common cause of PMB was the same as the conventional data. Interestingly, the proportion of patients with cervical cancer decreased during the latter half of the decade, reflecting the changes in the nation's cancer prevalence rate, while the use of HRT increased.
